The First Stereocontrolled Solid-Phase Synthesis of Di-, Tri-, and Tetra[adenosine (2‘,5‘) phosphorothioate]s-Reference-Cited by-同舟云学术

The First Stereocontrolled Solid-Phase Synthesis of Di-, Tri-, and Tetra[adenosine (2‘,5‘) phosphorothioate]s

Published:1998-09-11 Issue:20 Volume:63 Page:7097-7100
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Yang Xian-Bin¹,Sierzchała Agnieszka¹,Misiura Konrad¹,Niewiarowski Wojciech¹,Sochacki Marek¹,Stec Wojciech J.¹,Wieczorek Michał W.¹

Affiliation:

1. Polish Academy of Sciences, Centre of Molecular and Macromolecular Studies, Department of Bioorganic Chemistry, Sienkiewicza 112, 90-363 Łódź, Poland, and Institute of General Food Chemistry, Technical University of Łódź, Stefanowskiego 4/10, 90-924 Łódź, Poland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/jo980522l

Reference34 articles.

1. The Interferon System

2. Synthesis of (3′-5′), (2′-5′)-linked di- and tri-adenylyl methylphosphonate analogs

3. Synthesis and biological activities of a phosphorodithioate analog of 2′, 5′-oligoadenylate

4. Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.

5. Synthesis of P-thioadenylyl-(2'-5')-adenosine and P-thioadenylyl-(2'-5')-P-thioadenylyl-(2'-5')-adenosine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Convenient Method for the Synthesis of 2′‐O‐Cyanoethylated Nucleotides and Their Application in the Solid‐Phase Synthesis of Related RNA Analogs;Current Protocols;2023-11

2. CMC and regulatory aspects of oligonucleotide therapeutics;RNA Therapeutics;2022

3. Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities;Biomedical Chromatography;2017-10-04

4. Solid‐Phase Synthesis of RNA Analogs Containing Phosphorodithioate Linkages;Current Protocols in Nucleic Acid Chemistry;2017-09

5. Manufacturing of Oligonucleotides;Comprehensive Medicinal Chemistry III;2017